Rural Medicine A Tough Road To Travel – PharmAsia Summit
This article was originally published in PharmAsia News
Executive Summary
Many drug companies make it policy to try and reach all possible patients, but struggle to understand complex distribution systems in countries like China to reach low-income and rural patients.
You may also be interested in...
Merck, Simcere Form JV To Expand Access To Lifestyle Drugs Across China
SHANGHAI - Merck & Co. affiliate MSD signed an agreement to form a joint venture July 21 with Simcere Pharmaceutical Group that will see both companies expand access to critical lifestyle drugs across China
Sandoz, Taiwan’s TLC Ink Commercialization Deal For AmBisome Generic In U.S., EU
Sandoz will commercialize TLC’s liposomal amphotericin B product, a generic of Gilead’s AmBisome, in the U.S. and EU.
Taiwan Liposome Seeks To Teach Old Drugs New Tricks In China And Markets Far From Home
Taiwan Liposome Co. Ltd. has the funds and team to reach outside of its base in Taiwan to turn old drugs into new products and is looking for opportunities at Asia-specific product applications.